• SENSEX 81,087.69
    -97.89 (--0.12%)
  • BANKNIFTY 55,617.60
    -344.35 (--0.62%)
  • Tata Motors
    647.20 542.55(%)
  • Axis Bank
    1,060.20 934.00(%)
  • Vimta Labs
    677.30 235.00(%)
  • GE Vernova T&D
    2,871.15 2,871.15(%)
  • Netweb Technol.
    2,299.15 3,060.00(%)
  • Suzlon Energy
    66.80 86.04(%)
  • Kaynes Tech
    6,483.00 7,824.95(%)
  • M & M
    3,117.25 2,360.45(%)
  • PNB Housing
    803.30 746.10(%)
  • Waaree Energies
    3,163.55 3,740.75(%)
  • HDFC Bank
    2,010.00 1,593.20(%)
  • Jayaswal Neco
    48.32 26.06(%)
  • Skipper
    548.00 665.00(%)
  • Shree Refrigerat
    177.70 177.70(%)
  • Timex Group
    244.75 289.90(%)
  • Hind. Unilever
    2,728.10 3,034.50(%)
  • TCS
    3,000.00 3,000.00(%)
  • Ceinsys Tech
    1,750.85 538.20(%)
  • Swiggy
    386.25 297.00(%)
  • KIOCL
    374.20 461.35(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Syschem (India) Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 6001.0
  • ISIN : INE121D01036
44.69 0 (0.38%)
  • As on 02 Aug 2025 (EOD)

  • Today’s Low

    44.00

  • Today’s High

    45.50

  • Open

    44.00

  • Perv Close

    44.52

  • 52W Low

    35.33

  • 52W High

    56.00

Key Indicators

  • P/E(TTM)

    406.27

  • Mar.Cap (₹Cr.)

    194.46

  • Div & Yield %

    0.00

  • Book Value(₹)

    20.98

  • Debt-Equity Ratio

    0.38

  • AGM Date

    01-Aug-2025

  • EPS

    0.11

  • P/E Ratio

    406.27

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    194.46

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    43.51

  • BV (₹)

    21.00

  • Sales( ₹ in Cr.)

    331.68

  • NP (in Cr.)

    0.46

  • NP Var(%)

    -83.0

  • Div%

    0.0

  • CPS (₹)

    0.80

  • EPS (₹)

    0.10

  • Traded Value (₹ in Lakhs)

    194.46

  • 52 Week High

    56.00

  • 52 Week Low

    35.33

  • Price BSE

    45.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    194.46

  • P/C Ratio

    57.50

  • P/E Ratio

    425.60

  • Price Vs.BV

    0.10

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 233.48 130.38 65.63 74.41 88.02 109.60
Excise Duty 0.00 0.00 0.00 0.00 11.09 16.49
Net Sales 233.48 130.38 65.63 74.41 76.93 93.11
Other Income 0.17 0.25 0.13 0.26 0.09 0.08
Stock Adjustments 22.25 -1.12 0.88 -5.44 -1.27 2.30
Total Income 255.90 129.51 66.64 69.23 75.75 95.49
EXPENDITURE :            
Raw Materials 197.91 92.46 46.97 55.42 67.16 85.63
Power and Fuel Cost 2.84 2.15 2.39 2.87 1.89 1.57
Employee Cost 6.08 4.40 4.54 4.10 2.99 2.96
Other Manufacturing Expenses 4.35 2.95 3.46 2.92 1.02 0.16
Selling and Administration Expenses 37.32 18.30 8.41 8.47 1.66 1.00
Miscellaneous Expenses 0.25 0.35 0.18 0.36 1.05 0.51
Employee Benefit Expenses 6.08 4.40 4.54 4.10 2.99 2.96
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 248.75 120.61 65.95 74.14 75.77 91.83
Operating Profit 7.15 8.89 0.69 -4.90 -0.03 3.66
Interest 0.25 0.04 0.28 0.06 0.02 0.01
Gross Profit 6.90 8.85 0.41 -4.96 -0.05 3.65
Depreciation 2.79 2.70 2.58 2.35 2.15 2.15
Profit Before Tax 4.11 6.15 -2.17 -7.31 -2.20 1.50
Current Tax 0.00 0.00 0.00 0.00 0.00 0.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 1.35 1.64 -0.47 -1.75 -0.35 0.75
Reported Net Profit 2.76 4.51 -1.71 -5.57 -1.85 0.75
Extraordinary Items 0.00 0.00 0.00 -0.28 -0.03 -0.25
Adjusted Net Profit 2.76 4.51 -1.71 -5.29 -1.82 1.00
Adjustment below Net Profit 0.00 0.12 0.00 0.00 0.00 0.00
P & L Balance brought forward -13.87 -18.50 -16.79 -11.23 -9.37 -10.12
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down -11.10 -13.87 -18.50 -16.79 -11.23 -9.37
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 0.69 1.42 -0.73 -2.58 -0.99 0.40
Earnings Per Share(Adj)-Unit Curr 0.69 1.30 -0.67 -2.37 -0.91 0.37
Book Value 14.29 6.99 2.60 2.79 4.69 5.68
Book Value(Adj)-Unit Curr 14.29 6.42 2.39 2.56 4.31 5.22

Shareholding Pattern

  • Promoter Group

    56.71%

  • Public Share Holding

    43.29%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 24,676,110 56.71 24,676,110 10
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 24,676,110 56.71 24,676,110 10
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 80,000 0.18 80,000 1
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 80,000 0.18 80,000 1
2] Non Institution
Bodies Corporate 2,799,079 6.43 2,767,979 112
Clearing Members 1,000 0.00 1,000 1
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 351,023 0.81 193,823 245
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 1,045,307 2.40 1,045,307 261
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 7,604,860 17.48 7,604,860 97
Individuals holding nominal share capital up to Rs. 1 lakh 6,955,621 15.99 6,854,519 12,179
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 18,756,890 43.11 18,467,488 12,895
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 43,513,000 100.00 43,223,598 12,906

Company Background

Syschem (India) LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Syschem (India) Ltd
  • BSE Code : 6001.0
  • ISIN : INE121D01036

  • Incorporation Year

    1993

  • Registered Office

    Tehsil Kalka
    Bargodam Village, Panchkula,
    Haryana-133302

  • Telephone

    91-172-3077777

  • FAX

    91-172-3077700

  • Chairman

  • Managing Director

    Ranjan Jain

  • Company Secretary

    Shikha Kataria

  • Auditor

    STAV & Co

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Beetal Fin.& Comp. Ser.(P) Ltd
    Beetal House 99 ,
    Madangir Behind LSC ,Nr Dada Harsukhdar
    Mumbai - Delhi - 110062

Syschem (India) Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Syschem (India) 44.69 233.65 233.48 406.27 6.14
Abbott India 33,676.00 6,684.73 6,409.15 50.59 44.95
Astrazeneca Phar 8,893.15 1,756.92 1,716.29 192.08 32.94
P & G Health Ltd 6,199.70 1,166.89 1,151.26 40.97 39.76
Glaxosmi. Pharma 2,933.90 3,866.05 3,723.49 52.76 58.72
Cipla 1,501.20 20,029.57 19,044.85 22.44 21.40
Amrutanjan Healt 676.35 437.58 421.23 38.47 20.84
Guj. Themis Bio. 371.85 174.19 169.82 90.92 44.82
Fermenta Biotec. 362.00 442.21 430.53 15.76 17.61
Bliss GVS Pharma 173.70 703.42 667.20 25.96 9.16
Ambalal Sarabhai 32.97 19.33 4.04 30.53 2.10